Crohn's disease: open trials in Hungary

22 open trials have a site in Hungary. Registry data; only the trial team decides who can take part.

2024-518296-56-00
A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Bekes Varmegyei Koezponti Korhaz, Bekescsaba · Semmelweis University, Budapest · Clinexpert Kft., Budapest III · Central Hospital Of Northern Pest Military Hospital, Budapest VI · Pannonia Maganorvosi Centrum Kft., Budapest XIII · Heves Varmegyei Markhot Ferenc Oktatokorhaz Es Rendelointezet, Eger · Gyoengyosi Bugat Pal Koerhaz, Gyongyos · Komarom-Esztergom Varmegyei Szent Borbala Korhaz, Tatabánya · VeszLife Kft., Veszprem
Registry updated 2026-11-08
NCT06226883
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2 · Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Bekes Varmegyei Koezponti Korhaz, Bekescsaba · Semmelweis University, Budapest VIII · Heves Varmegyei Markhot Ferenc Oktatokorhaz Es Rendelointezet, Eger · Gyöngyösi Bugát Pál Kórház, Gyongyos · Fejer Varmegyei Szent Gyoergy Egyetemi Oktato Korhaz, Szekesfehervar · Clinfan Kft., Szekszard
Registry updated 2026-11-04
NCT06937099
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Trial Treatment · Phase 3 · Eli Lilly and Company
Semmelweis Egyetem, Budapest · Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont, Szeged · CLINFAN Szolgáltató Kft, Szekszárd
Registry updated 2026-11-04
NCT07483073
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Trial Treatment · Phase 2 · Eli Lilly and Company
Semmelweis University, Budapest · Geomedical Kft., Budapest VI · Komarom-Esztergom Varmegyei Szent Borbala Korhaz, Tatabánya
Registry updated 2026-11-04
NCT07483099
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Trial Treatment · Phase 2 · Eli Lilly and Company
Semmelweis Egyetem, Budapest · Geomedical Egészségügyi Központ, Budapest · Komarom-Esztergom Varmegyei Szent Borbala Korhaz, Tatabánya
Registry updated 2026-11-04
NCT06651281
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Bekes Varmegyei Koezponti Korhaz, Bekescsaba · Semmelweis University, Budapest
Registry updated 2026-11-03
NCT07196722
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC
Bekes Varmegyei Koezponti Korhaz, Bekescsaba · Semmelweis University, Budapest · Obudai Egeszseguegyi Centrum Kft., Budapest III · Semmelweis University, Budapest VIII · Pannonia Maganorvosi Centrum Kft., Budapest XIII · University of Debrecen, Debrecen · Heves Varmegyei Markhot Ferenc Oktatokorhaz Es Rendelointezet, Eger · University of Szeged, Szeged · Clinfan Kft., Szekszard · Komarom-Esztergom Varmegyei Szent Borbala Korhaz, Tatabánya
Registry updated 2026-11-03
NCT07363044
A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease
Trial Treatment · Alimentiv Inc.
Semmelweis Egyetem Sebészeti, Budapest · Eszak-Pesti Centrumkórház-Honvédkórház, Budapest · Debreceni Egyetem Klinikai Kozpont, Debrecen · Pécsi Tudományegyetem Klinikai Központ, Pécs · Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont, Szeged
Registry updated 2026-11-03
NCT07499232
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Endomedix, Budapest · Obudai Egeszsegugyi Centrum Kft, Budapest · Semmelweis Egyetem 1, Budapest · Pannónia Magánorvosi Centrum Kft, Budapest · Semmelweis Egyetem, Budapest · Semmelweis Egyetem 2, Budapest · Clinexpert Gyöngyös Kft., Gyöngyös · Szegedi Tudomanyegyetem, Szeged
Registry updated 2026-11-03
NCT07577843
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Semmelweis University, Budapest · Semmelweis University, Budapest VIII · Pannonia Maganorvosi Centrum Kft., Budapest XIII · University of Szeged, Szeged
Registry updated 2026-11-03
NCT06233461
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2 · Takeda
Semmelweis University, Budapest · Clinexpert Kft., Budapest III · Pannonia Maganorvosi Centrum Kft., Budapest XIII · EURO-ENDO-MED Kft., Mohács
Registry updated 2026-11-02
NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Bekes Varmegyei Koezponti Korhaz, Bekescsaba · Semmelweis University, Budapest · Clinexpert Kft., Budapest III · Central Hospital Of Northern Pest Military Hospital, Budapest VI · Pannonia Maganorvosi Centrum Kft., Budapest XIII · Heves Varmegyei Markhot Ferenc Oktatokorhaz Es Rendelointezet, Eger · Gyoengyosi Bugat Pal Koerhaz, Gyongyos · Komarom-Esztergom Varmegyei Szent Borbala Korhaz, Tatabánya · VeszLife Kft., Veszprem
Registry updated 2026-11-02
NCT06819891
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Hoffmann-La Roche
Endomedix Kft., Budapest · Semmelweis University, Budapest · Geomedical Kft., Budapest VI · Central Hospital Of Northern Pest Military Hospital, Budapest VI · Vas-Oxy Kft, Szombathely
Registry updated 2026-10-26
NCT07184931
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Sanofi
Budapest · Budapest · Eger · Tatabánya · Veszprém
Registry updated 2026-10-21
NCT06819878
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Hoffmann-La Roche
Bekes Varmegyei Koezponti Korhaz, Bekescsaba · Obudai Egeszseguegyi Centrum Kft., Budapest III · Semmelweis University, Budapest VIII · Pannonia Maganorvosi Centrum Kft., Budapest XIII · Clinexpert Gyoengyoes Kft., Gyongyos · Fejer Varmegyei Szent Gyoergy Egyetemi Oktato Korhaz, Szekesfehervar · Clinfan Kft., Szekszard
Registry updated 2026-10-16
NCT06548542
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Trial Treatment · Phase 2 · AbbVie
Semmelweis University, Budapest · Semmelweis University, Budapest VIII · University of Debrecen, Debrecen · University of Szeged, Szeged · Clinfan Kft., Szekszard
Registry updated 2026-09-25
2025-521590-13-00
Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year
Trial Treatment · Phase 3 · Janssen Cilag International
Semmelweis University, Budapest · Obudai Egeszseguegyi Centrum Kft., Budapest III · Semmelweis University, Budapest VIII · Pannonia Maganorvosi Centrum Kft., Budapest XIII · Endomedix Kft., Budapest XIII · Clinexpert Gyoengyoes Kft., Gyongyos · University of Szeged, Szeged
Registry updated 2026-08-28
NCT06227910
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Trial Treatment · Phase 3 · Takeda
Semmelweis University, Budapest · Central Hospital Of Northern Pest Military Hospital, Budapest VI · University of Szeged, Szeged
Registry updated 2026-05-27
NCT06764615
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Trial Treatment · Phase 2 · Takeda
Semmelweis University, Budapest · Clinexpert Kft., Budapest III · Pannonia Maganorvosi Centrum Kft., Budapest XIII · EURO-ENDO-MED Kft., Mohács
Registry updated 2026-05-22
NCT05442567
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Trial Treatment · Phase 3 · Takeda
Clinexpert Kft., Budapest III · Semmelweis University, Budapest VIII · Borsod-Abauj-Zemplen Varmegyei Koezponti Korhaz Es Egyetemi Oktatokorhaz, Miskolc
Registry updated 2026-05-07
NCT04779320
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Trial Treatment · Phase 3 · Takeda
Clinexpert Kft., Budapest III · Semmelweis University, Budapest VIII · Borsod-Abauj-Zemplen Varmegyei Koezponti Korhaz Es Egyetemi Oktatokorhaz, Miskolc
Registry updated 2026-05-05
NCT06456593
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2 · Abivax S.A.
Bekes Varmegyei Koezponti Korhaz, Bekescsaba · Semmelweis University, Budapest · Obudai Egeszseguegyi Centrum Kft., Budapest III · Geomedical Kft., Budapest VI · Semmelweis University, Budapest VIII · Pannonia Maganorvosi Centrum Kft., Budapest XIII · Gyoengyosi Bugat Pal Koerhaz, Gyongyos · Csőszi Endoszkópia Rendelő, Kecskemét · Fejer Varmegyei Szent Gyoergy Egyetemi Oktato Korhaz, Szekesfehervar · Clinfan Kft., Szekszard · Komarom-Esztergom Varmegyei Szent Borbala Korhaz, Tatabánya
Registry updated 2026-04-27

All Crohn's disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error